Skip to content
StockMarketAgent
Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0JZ2 stock hub

LON/0JZ2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0JZ2is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.9B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0JZ2
In the news

Latest news · LON/0JZ2

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.8
P25 12.9P50 16.9P75 23.5
Trailing P/E118.5
P25 15.9P50 22.9P75 35.8
ROE25
P25 -54.2P50 2.1P75 13.7
ROIC22.2
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0JZ2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
214
Groups with data
11
Currency
USD
Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
UK
Employees
2,200
Employees Change
-200%
Employees Change Percent
-5.26
Enterprise value
$7.1B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical - Equipment & Services
Isin
US5747951003
Last refreshed
2026-05-10
Market cap
$6.9B
Price
$178
Price currency
USD
Rev Per Employee
536,715.52x
Sector
Healthcare
Sic
3845
Symbol
lon/0JZ2
Website
https://www.masimo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
0.84%
EV Earnings
123.13x
EV/EBIT
30.2x
EV/EBITDA
25.75x
EV/FCF
44.55x
EV/Sales
6.22x
FCF yield
2.33%
Forward P/E
28.82x
P/B ratio
11.46x
P/E ratio
118.54x
P/S ratio
5.8x
PE Ratio10 Y
50.93x
PE Ratio5 Y
70.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
20.6%
EBITDA Margin
23.59%
FCF margin
13.53%
Gross margin
61.63%
Gross Profit
$727.7M
Gross Profit Growth
14.82%
Gross Profit Growth Q
7.18%
Gross Profit Growth3 Y
-5.52%
Gross Profit Growth5 Y
4.95%
Net Income
$57.8M
Net Income Growth Quarters
2%
Net Income Growth Years
1%
Net Income Growth3 Y
-13.58%
Net Income Growth5 Y
-19.75%
Pretax Margin
17.68%
Profit Margin
4.9%
Profit Per Employee
$26,276
ROA
10.2
Roa5y
6.19
ROCE
24.38
ROE
24.99
Roe5y
11.64
ROIC
22.18
Roic5y
13.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr1y
19.42%
Cagr3y
-1.7%
Cagr5y
-4.48%
EPS Growth Quarters
2
EPS Growth Years
1
EPS Growth3 Y
-13.19
EPS Growth5 Y
-18.46
FCF Growth
28.52%
FCF Growth Q
43.86%
FCF Growth5 Y
2.83%
OCF Growth
27.68%
OCF Growth Q
45.66%
OCF Growth10 Y
7.1%
OCF Growth3 Y
227.58%
OCF Growth5 Y
0.36%
Revenue Growth
9.17x
Revenue Growth Q
8.5x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
-12.12x
Revenue Growth5 Y
5.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.79
Assets
$1.2B
Cash
$94.4M
Current Assets
$638.5M
Current Liabilities
$238.7M
Debt
$368.1M
Debt EBITDA
$1.29
Debt Equity
$0.62
Debt FCF
$2.3
Equity
$597.7M
Interest Coverage
10.53
Liabilities
$646.9M
Long Term Assets
$606M
Long Term Liabilities
$408.2M
Net Cash
$-273.7M
Net Cash By Market Cap
$-3.99
Net Debt EBITDA
$0.98
Net Debt Equity
$0.46
Net Debt FCF
$1.71
Tangible Book Value
$482.6M
Tangible Book Value Per Share
$9.22
WACC
10.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.68
Inventory Turnover
1.71
Net Working Capital
$329.6M
Quick ratio
1.27
Working Capital
$413M
Working Capital Turnover
$2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
19.41%
200-day SMA
153.8
3Y total return
-5.03%
50-day SMA
177.5
50-day SMA vs 200-day SMA
50over200
5Y total return
-20.49%
All Time High
304.6
All Time High Change
-41.45%
All Time High Date
2021-11-19
All Time Low
75.35
All Time Low Change
136.72%
All Time Low Date
2023-10-17
ATR
0.88
Beta
1.13
Ch YTD
36.77
High
178.5
High52
182
High52 Date
2026-02-17
High52ch
-1.99%
Low
177
Low52
126.6
Low52 Date
2026-01-05
Low52ch
40.93%
Ma50ch
0.49%
Price vs 200-day SMA
15.96%
RSI
60.5
RSI Monthly
58.23
RSI Weekly
65.47
Sharpe ratio
0.45x
Sortino ratio
1
Total Return
-0.19%
Tr YTD
36.77
Tr1m
-0.15%
Tr1w
-0.1%
Tr3m
31.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$243.3M
Operating Income Growth
80.49
Operating Income Growth Q
18.09
Operating Income Growth3 Y
16.15
Operating Income Growth5 Y
4.92
Operating margin
20.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
47,632,481%
Net Borrowing
-145,162,420.6
Shares Insiders
0.22%
Shares Institutions
89.16%
Shares Qo Q
-0.19%
Shares Yo Y
0.19%
Short Ratio
2.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
$132.8M
Average Volume
30.2x
Bv Per Share
11.41
CAPEX
$-16M
Ch1m
-0.15
Ch1w
-0.1
Ch1y
19.41
Ch3m
31.82
Ch3y
-5.03
Ch5y
-20.49
Ch6m
23.03
Change
-0.04%
Change From Open
0.49
Close
178.5
Days Gap
-0.53
Depreciation Amortization
34,181,752.4
Dollar Volume
2,140.4
Earnings Date
2026-05-05
EBIT
$243.3M
EBITDA
$278.6M
EPS
$1.08
F Score
8
FCF
$159.8M
FCF EV Yield
2.24x
Financing CF
-411,471,569
Fiscal Year End
January
Founded
1,989
Goodwill
74,011,562.6
Graham Number
22.9508
Graham Upside
-87.13
Income Tax
$44.5M
Investing CF
197,136,627
Is Primary Listing
0
Last Earnings Date
2026-02-26
Last Report Date
2026-04-04
Lynch Fair Value
$7.52
Lynch Upside
-95.78
Ma150
154.8
Ma150ch
15.19%
Ma20
178.5
Ma20ch
-0.06%
Net CF
-39,321,257
Open
177.5
P FCF Ratio
42.89
P OCF Ratio
38.99
Position In Range
90.73
Ppne
284,016,620.8
Price Date
2026-05-08
Price EBITDA
$24.6
Ptbv Ratio
14.2
Relative Volume
0.35x
Revenue
1,180,774,148x
SBC By Revenue
2.28x
Share Based Comp
26,971,806
Tax By Revenue
3.77x
Tax Rate
21.31%
Tr6m
23.03%
Volume
12
Z Score
8.97
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0JZ2 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0JZ2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+19.4%
S&P 500 1Y: n/a
3Y total return
-5.0%
S&P 500 3Y: n/a
5Y total return
-20.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0JZ2?

Insider, institutional, and short-interest positioning.

Institutional ownership
+89.2%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.3 days to cover
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

LON/0JZ2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.5
Neutral momentum band
Price vs 200-day MA
+16.0%
50/200-day relationship not available
Beta (5Y)
1.13
Moves roughly with the market
Sharpe ratio
0.45
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0JZ2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JZ2 stock rating?

lon/0JZ2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JZ2 analysis?

The full report lives at /stocks/lon/0JZ2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JZ2?

The latest report frames lon/0JZ2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JZ2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

lon/0JZ2 stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام